Morgan Stanley Knock-Out RMBS/ DE000MB28GH1 /
2024-05-30 9:03:40 AM | Chg.-0.10 | Bid12:56:52 PM | Ask12:56:52 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
1.67EUR | -5.65% | 1.68 Bid Size: 1,000 |
1.75 Ask Size: 1,000 |
Rambus Inc | 36.4175 - | 2078-12-31 | Call |
GlobeNewswire
1:00 PM
Elevar Therapeutics Reports Landmark Median Overall Survival of 23.8 Months in First-Line Treatment ...
GlobeNewswire
1:00 PM
Troilus Discovers New At-Surface Gold Zone ‘West Rim’ With Intercept of 1.37 g/t AuEq Over 11m Withi...
GlobeNewswire
1:00 PM
BiomX to Present Phase 1b/2a Clinical Trial Data for BX004 at the 47th European Cystic Fibrosis Conf...
GlobeNewswire
1:00 PM
Beamr Cloud upgrade for enterprises: customizable video service with enhanced security and privacy
GlobeNewswire
1:00 PM
Fortrea Introduces Comprehensive Solution to Improve Diversity and Inclusion in Clinical Research
GlobeNewswire
1:00 PM
SERB Pharmaceuticals appoints Vanessa Wolfeler as CEO to drive next stage of the company’s growth
GlobeNewswire
1:00 PM
Tiziana Life Sciences Scientific Board Chairman to Receive Prestigious Award for Multiple Sclerosis ...
GlobeNewswire
1:00 PM
17 Education & Technology Group Inc. to Report First Quarter 2024 Unaudited Financial Results on Jun...
GlobeNewswire
1:00 PM
Roivant Reports Financial Results for the Fourth Quarter and Fiscal Year Ended March 31, 2024, and P...
GlobeNewswire
1:00 PM
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line Trea...
GlobeNewswire
1:00 PM
Rivalry Reports First Quarter 2024 Results, Expands Into Crypto Segment Through Rivalry Token
GlobeNewswire
1:00 PM
Virtu Financial, Inc. Announces Investor Meetings for Potential Opportunistic Offering of Senior Sec...